LONDON, April 19, 2021 / PRNewswire / – Alphagreen, Europe The leading marketplace for cannabis products launches the biggest crowdfunding increase ever in CBD and medical cannabis.
The cash injection will be used to grow its e-commerce and digital marketing activities, expand into new global territories, and leverage its industry expertise to enter the emerging medical cannabis market.
The deal got off to a strong start and has already raised £ 1.5m in the past few days. Existing investors include StockholmEnexis AB, US cannabis fund West Creek Investments and angel investors including Igor and Oleg Tikhturov.
Co-founder and CEO of Alphagreen, Alexei Pikovsky“The cannabis industry is here to stay. The global market is facing significant growth and Alphagreen is perfectly positioned to benefit from increased use of medical cannabis and fundamental changes to the way the cannabis and CBD markets work.” “”
Alphagreen has seen phenomenal growth since its inception October 2019and it has been uniquely able to benefit from the shift to online retailing and increased interest in wellness products as a result of the pandemic.
At the beginning of trading, Alphagreen listed four brands and 50 products. Today the CBD marketplace sells more than 150 brands with more than 2,500 products. Revenue rose from £ 23,562 in the second quarter of 2020 to £ 130,000 in the first quarter of 2021, a growth of more than 450%.
Alphagreen not only generates revenue from the growing number of companies wanting to list products on its platform, it also offers comprehensive e-commerce technology services including SEO, business intelligence (data collection; data and market trend analysis) and one of the largest hubs for content creation, including 1,000+ top influencers who access and are part of Alphagreen’s e-commerce channel.
One of the key factors in Alphagreen’s success to date has been a content-first strategy that created unique and well-researched content that resulted in strong search rankings. In fact, more than five million words of exclusive content have been created in the past 12 months. As a result, Alphagreen’s content has risen to a top ranking on Google within Google in the UK and several other European countries including Germany, France, Spain and Italy.
Cannabis products are one of the fastest growing markets in the world, with an estimated average annual growth rate (CAGR) of around 22%.
Alphagreen focuses on the common challenges of sleep, anxiety and pain, unprecedented market intelligence, market innovations designed to shake up the health and wellness space, and a content-driven marketing strategy. Alphagreen expects further growth of 300% for 2021.
Alexei Pikovsky adds, “We’re well on our way to ending the year close to a million pounds in sales and should take a huge leap forward in 2022 if our first content strategy along with our e-commerce marketplace is the best in terms of” Health and Wellness shows brand innovations and portfolios as well as massive web traffic that any business wants to participate in. We are uniquely positioned and look forward to working with the best brands worldwide. “
About the Alphagreen Group:
The Alphagreen Group is an e-commerce platform and technology provider focused on CBD and other alternative health products. It works Europe The leading platform for CBD provides a comprehensive marketplace for wellness and beauty consumers and brands, offers trustworthy and effective CBD products for the relief of mental and physical ailments, and is expanding into other niche industries including medical cannabis and nootropics.
Alphagreen was founded in 2019 and was born out of a passion for health and well-being, combined with technology and innovation.
The idea of entrepreneurs Alexei Pikovsky and Viktor Khliupko, Alphagreen, is designed to simplify the entire CBD and alternative health product experience on every step of the consumer journey.
For more information, please contact:
Nicky Smith:: [email protected];; +44 (0) 7867 513 361, +44 (0) 2036000228
Sophie Woolford:: [email protected];; +44 (0) 7825 347 446, +44 (0) 2036000228